| Title[sort] |
Cycle |
Award[sort] |
| A Novel Biological Framework for the Role of Xenoestrogens |
2006 (Cycle 12) |
$279,242 |
| Investigator(s): Shanaz Dairkee , Ph.D. |
12IB-0115 |
| Inhibition of Breast Cancer Aggressiveness by Cannabidiol |
2006 (Cycle 12) |
$183,000 |
| Investigator(s): Sean McAllister , Ph.D. |
12IB-0116 |
| Discovering Novel Cell-ECM Interactions in Breast Cells |
2004 (Cycle 10) |
$159,939 |
| Investigator(s): John Muschler , Ph.D. |
10IB-0067 |
| FKBP Proteins as Molecular Targets in Breast Cancer Therapy |
2004 (Cycle 10) |
$88,906 |
| Investigator(s): Sylvia Fong , Ph.D. |
10FB-0122 |
| Molecular Pathogenesis of Metastatic Breast Cancer |
2002 (Cycle VIII) |
$311,367 |
| Investigator(s): Robert Debs , M.D. |
8WB-0164 |
| Infinite Expansion of Breast Tumor Samples in Culture |
2002 (Cycle VIII) |
$311,400 |
| Investigator(s): Shanaz Dairkee , Ph.D. |
8WB-0032 |
| Child's Stress During Mother's Treatment for Breast Cancer |
2001 (Cycle VII) |
$127,553 |
| Investigator(s): Ellen Levine , Ph.D., M.P.H. |
7XB-0072 |
| Child's Stress During Mother's Treatment for Breast Cancer |
2001 (Cycle VII) |
$127,553 |
| Investigator(s): Dalia Ducker , Ph.D. |
7XB-0072 |
| Role of Id-2 in Breast Cancer and its Relationship to Id-1 |
2001 (Cycle VII) |
$296,531 |
| Investigator(s): Pierre-Yves Desprez , Ph.D. |
7WB-0026 |
| Enhanced HER-2 Directed Liposomal Therapeutics |
2001 (Cycle VII) |
$332,938 |
| Investigator(s): Daryl Drummond , Ph.D. |
7KB-0066 |
| Tumor Suppression by Dystroglycan in Breast Epithelial Cells |
2001 (Cycle VII) |
$302,190 |
| Investigator(s): John Muschler , Ph.D. |
7KB-0017A |
| Genetic Changes in Normal Epithelium of the Cancerous Breast |
2000 (Cycle VI) |
$616,342 |
| Investigator(s): Shanaz Dairkee , Ph.D. |
6PB-0083 |
| Id-1 Expression During Breast Cancer Progression |
1999 (Cycle V) |
$78,031 |
| Investigator(s): Pierre-Yves Desprez , Ph.D. |
5IB-0111 |
| Identification of Novel Id-1 Regulated Genes in Breast Cells |
1999 (Cycle V) |
$75,600 |
| Investigator(s): Jarnail Singh , Ph.D. |
5FB-0112 |
| A New System for Breast Cancer Drug Delivery |
1998 (Cycle IV) |
$73,185 |
| Investigator(s): Daryl Drummond , Ph.D. |
4FB-0154 |
| Molecular Mapping of Surgical Margins |
1998 (Cycle IV) |
$287,992 |
| Investigator(s): Shanaz Dairkee , Ph.D. |
4CB-0134 |
| The Efficacy of Retreat for Low-Income Women with Breast Can |
1997 (Cycle III) |
$87,499 |
| Investigator(s): Ellen Levine , Ph.D., M.P.H. |
3AB-2801 |
| Novel Breast Cancer Epithelial Cell Metalloproteinase |
1997 (Cycle III) |
$193,995 |
| Investigator(s): Pierre-Yves Desprez , Ph.D. |
3IB-0123 |
| Gene Therapy for Breast Cancer |
1997 (Cycle III) |
$293,383 |
| Investigator(s): Robert Debs , M.D. |
3CB-0039 |
| Improved Delivery of Pharmaceuticals to Breast Cancer |
1996 (Cycle II) |
$60,597 |
| Investigator(s): Dmitri Kirpotin , Ph.D. |
2CB-0004A |
| The Invasive Nature of Epithelial Breast Cancer Cells |
1995 (Cycle I) |
$269,852 |
| Investigator(s): Pierre-Yves Desprez , Ph.D. |
1KB-0274A |
| A Candidate Breast Tumor Suppressor Gene on Chromosome 13 |
1995 (Cycle I) |
$305,953 |
| Investigator(s): David Schott , Ph.D. |
1RB-0218 |
